medRxivGenetic & Genomic MedicinePreprint
Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing
Wouter SteyaertiD, Lydia SagathiD, German M. DemidoviD, Vicente A. YépeziD, Anna Esteve‐CodinaiD, Julien GagneuriD, Kornelia EllwangeriD, Ronny C. DerksiD, Marjan M. WeissiD, Amber den OudeniD, Simone van den Heuvel, Hilde L. Swinkels, Nick ZomeriD, Marloes SteehouweriD, Luke O’GormaniD, Galuh AstutiiD, Kornelia NevelingiD, Rebecca SchüleiD, Jishu XuiD, Matthis SynofzikiD, Danique BeijeriD, Holger HengeliD, Ludger J. SchölsiD, Kristl G. ClaeysiD, Jonathan BaetsiD, , Alexander HoischeniD
Abstract
Solve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilised 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single nucleotide variants (SNVs), insertion-deletions (InDels), and short tandem repeat (STR) expansions in extensively studied RD families without clear molecular diagnoses. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Rare Disease Network (ERN) experts. Of these, 21 families were affected by so-called unsolvable syndromes for which genetic causes remain unknown, and 93 families with at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without genetic diagnosis despite extensive prior testing. Clinical interpretation and orthogonal validation of variants in known disease genes yielded thirteen novel genetic diagnoses due to de novo and rare inherited SNVs, InDels, SVs, and STR expansions. In an additional four families, we identified a candidate disease-causing SV affecting several genes including an MCF2/FGF13 fusion and PSMA3 deletion. However, no common genetic cause was identified in any of the unsolvable syndromes. Taken together, we found (likely) disease-causing genetic variants in 13.0% of previously unsolved families and additional candidate disease-causing SVs in another 4.3% of these families. In conclusion, our results demonstrate the added value of HiFi long-read genome sequencing in undiagnosed rare diseases.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: experimental assay
- Citations
- 18
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HiFi long-read genomes for difficult-to-detect clinically relevant variants
Wolfram Höps, Marjan M. Weiss, … Lisenka E.L.M. Vissers·The American Journal of Human GeneticsPeer-reviewed·Jan 13, 2025
- Structural variant discovery and diagnostic impact in rare diseases from short-read and long-read sequencing
Alba Sanchis‐Juan, Yulia Mostovoy, … Michael E. Talkowski·medRxiv·Jun 24, 2026
- Pangenome-based identification of cryptic pathogenic variants in undiagnosed rare disease patients
S. Jang, Seoyeon Kim, … Jong‐Hee Chae·medRxiv·Jul 8, 2025
- Long-read genome sequencing and variant reanalysis increase diagnostic yield in neurodevelopmental disorders
Susan M. Hiatt, James M.J. Lawlor, … Gregory M. Cooper·Genome ResearchPeer-reviewed·Nov 1, 2024
- Genomic Research as a Critical Pathway to Diagnosis for Individuals with Rare Disease
Anne O’Donnell‐Luria, Stephanie P. DiTroia, … Heidi L. Rehm·medRxiv·Sep 20, 2026
- Identification of Pathogenic Structural Variants in Rare Disease Patients through Genome Sequencing
James Holt, Camille L. Birch, … Elizabeth A. Worthey·bioRxiv·May 15, 2019